ClinicalTrials.gg
CompletedNCT01373320Updated Oct 23, 2013

Faith Moves Mountains: A Community Based Participatory Research (CBPR) Appalachian Wellness & Cancer Prevention Program

An interventional study of Lay health advisor interactions in Lung Cancer, Cervical Cancer and Breast Cancer, sponsored by Nancy Schoenberg. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-10-23.

Sponsored by Nancy Schoenberg · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,415
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 2,462 studies in Lung Neoplasms with a site in United States — 423 open to participants now, 644 under way, 52 of them phase 3. Lung Neoplasms · United States.

Enrollment
44th of 1,908
1,415 · median 48
Started
2010
with 64 others
No phase
523 of 2,462
126 open now
Registered
988th of 2,462
by date

Among the 2,462 studies in Lung Neoplasms with a site in United States, this one is the 44th largest by enrollment of the 1,908 interventional ones that give a count, is one of 65 that started in 2010, is one of 523 with no phase, and was the 988th registered.

Lung Neoplasms

5,436 studies on the registry are indexed under Lung Neoplasms; 1,350 are open to participants now.

Browse Lung Neoplasms studies →

Open to participants now

423 of the 2,462 studies in Lung Neoplasms with a site in United States are open now. Recruiting first, the newest first:

418 more — sign in →

All 423 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 997 Lung Neoplasms studies recruiting now, 686 (69%) set no upper age limit and 143 (14%) stop at 75 or younger; 45 take children under 18; 143 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 2,462 studies in Lung Neoplasms with a site in United States, or all of them as a file.
02

Study summary

The study purpose is to evaluate the effectiveness of a set of culturally appropriate, faith-placed lay health advisor interventions aimed at facilitating smoking cessation and increasing cancer screening among Appalachian participants.

Read the detailed description

The developmental phase of this project incorporated community based participatory research (CBPR) principles to identify the needs and preferences of community members with regard to cancer prevention. In the intervention phase, this group-randomized trial administers and evaluates a set of culturally appropriate interventions aimed at facilitating smoking cessation and increasing cancer screening among participants in 6 distressed Appalachian counties. Faith institutions are recruited and randomized to treatment or wait-list control conditions, and participants are recruited and enrolled within those institutions. Participants select one or more targeted health behaviors from a menu including smoking cessation, colorectal cancer screening, cervical cancer screening, and breast cancer screening, and subsequently receive the intervention(s) aimed at their selected health behaviors.

03

Conditions studied

  • Lung Cancer
  • Cervical Cancer
  • Breast Cancer
  • Colorectal Cancer

Keywords

  • Smoking cessation
  • Cancer screening
  • Appalachia
  • Group-randomized trial
  • Faith-placed
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • For smoking cessation: age 18 or older; current cigarette smoker; able to provide
  • For cervical cancer screening: female; age 18 or older AND outside of screening guidelines; able to provide informed consent
  • For breast cancer screening: female; age 40 or older AND outside of screening guidelines; able to provide informed consent
  • For colorectal cancer screening: age 40 or older AND outside of screening guidelines; able to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • For smoking cessation: None
  • For cervical cancer screening: History of cervical cancer; history of hysterectomy
  • For breast cancer screening: History of breast cancer
  • For colorectal cancer screening: History of colorectal cancer
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
1,415 participants (actual)

Study arms

  • Experimental
    Early Intervention

    Participants in this group are nested in churches which were randomly assigned to the treatment group.

    Behavioral: Lay health advisor interactions

  • No intervention
    Delayed Intervention

    Participants in this group are nested in churches which were randomly assigned to the wait-list control group. They receive an educational luncheon focused on stress reduction during the intervention window for the Early Intervention group, and subsequently receive the intervention(s) for their selected target health behaviors at a later date.

Interventions

  • BehavioralLay health advisor interactions

    For smoking cessation: Cooper-Clayton group sessions plus motivational interviewing, both delivered by local lay health advisor. For all cancer screenings: lay health advisor home visits incorporating motivational interviewing and focused on decreasing participant-identified barriers to screening.

06

What researchers measure

Primary outcomes

  1. Proportion of participants reporting the health behavior of interest (depending on which intervention component(s) were selected)

    For smoking cessation: Self-reported smoking status. For cancer screenings: Self-reported receipt of cervical, breast, and/or colorectal cancer screening. This assessment occurs after the Early Treatment group has completed the intervention.

    Time frame: Assessed approximately 4 months after baseline

Secondary outcomes

  1. Change in stage of readiness to change the selected health behavior(s) from baseline

    Measured using reliable and valid instruments which were pretested in focus groups comprised of members of the target population. Positive change (i.e., increasing stage of readiness) from baseline to post-test will be coded as "1," while negative or no change will be coded "0." This assessment occurs after the Early Treatment group has completed the intervention.

    Time frame: Assessed approximately 4 months after baseline

  2. Number of visits completed

    This process measure will reflect the number of visits/classes attended by participants, as a means of assessing participation rate and feasibility.

    Time frame: Approximately 4 months after baseline

  3. Retention (i.e., number of participants who complete all planned assessment timepoints)

    Retention numbers will be assessed as a process measure outcome. Participants who complete all study assessment timepoints will be coded as "1," while participants who drop out will be coded "0." Number/percentage of participants who remained enrolled and complete all study procedures and assessments will be used as an indicator of feasibility in the community setting.

    Time frame: Approximately one year after baseline

07

Study locations

1 site
  • Faith Moves Mountains
    Whitesburg, Kentucky, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2010, a primary completion of Nov 2012 and a completion of Nov 2012. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 10, 2011
First posted
Jun 14, 2011
Start
Mar 2010
Primary completionActual
Nov 2012
CompletionActual
Nov 2012
Last update
Oct 23, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 23, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01373320
Lead sponsor
Nancy Schoenberg
Responsible party
Nancy Schoenberg (Sponsor/PI, University of Kentucky) — Sponsor-investigator
First posted
Jun 14, 2011
Start date
Mar 2010
Primary completion
Nov 2012
Completion
Nov 2012
Last update
Oct 23, 2013

Study contacts

Nancy Schoenberg, Ph.D.
principal investigator · University of Kentucky

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion